Targeted drug delivery solutions for drug discovery

Maximise the impact of your drug deliveries with a more targetted approach while reducing off-target effects, with our solutions that utilise the specificity offered by lipid nanoparticles.

Why are lipid nanoparticles such an effective method of targeted drug delivery?

Lipid nanoparticles (LNPs) are highly effective for targeted drug delivery because they are biocompatible, biodegradable, and can encapsulate and protect a wide range of therapeutic molecules - like mRNA, siRNA, and small drugs - from degradation. Their small size and lipid composition allow efficient uptake by cells, and they can be engineered for both passive and active targeting to specific tissues or cell types. Additionally, their properties - such as size, charge, and surface modifications - can be precisely tuned to improve stability, circulation time, and delivery efficiency, making them a versatile and clinically validated platform.

Why choose Cayman Chemical for your targeted drug delivery needs?

Cayman Chemical’s lipid nanoparticle (LNP) product range is designed to support every stage of therapeutic development, offering enhanced drug delivery efficiency and reduced toxicity through high-quality, biocompatible lipid formulations. Their LNP solutions are scalable from early-stage research to GMP-grade production, making them ideal for both discovery and clinical pipelines. With easy customisation options, a selection of ready-to-use formulations, and comprehensive analytical and quality control support, Cayman empowers researchers to streamline development while maintaining precision, safety, and consistency across projects.

Benefits of using Cayman Chemical LipidLaunch range

• Research-ready LNPs
• Easy-to-use options for RNA encapsulation without needing specialised equipment
• Highly optimised lipid formulation to reduce toxicity
   

Materials to download
Cayman Currents LNP edition
Cayman LNP formulation guide